Effects of hydroxyethyl starch administration on renal function in critically ill patients.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  British Journal of Anaesthesia

• Publication date

  2005-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00003246-200512002-00617PMID 17251213
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The risk associated with aprotinin in cardiac surgery.

  2006cited by this paper
• Sepsis in European intensive care units: Results of the SOAP study*

  2006cited by this paper
• A systematic review of the comparative safety of colloids.

  2004cited by this paper
• [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].

  2004cited by this paper
• RETRACTED ARTICLE: Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin

  2003cited by this paper
• Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury

  2003cited by this paper
• Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery.

  2003cited by this paper
• Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.

  2001cited by this paper
• Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.

  2001cited by this paper
• Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient.

  2001cited by this paper
• Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.

  2001cited by this paper
• Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.

  2001cited by this paper
• The influence of different intravascular volume replacement regimens on renal function in the elderly.

  1999cited by this paper
• Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis.

  1999cited by this paper
• Hydroxyethylstarch-associated transient acute renal failure after epidural anaesthesia for labour analgesia and Caesarean section.

  1998cited by this paper
• Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

  1998cited by this paper
• Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.

  1996cited by this paper
• [Acute effects of complete blood exchange with ultra-purified hemoglobin solution or hydroxyethyl starch on liver and kidney in the animal model].

  1996cited by this paper
• Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients.

  1996cited by this paper
• The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure

  1996cited by this paper
• Acute renal failure in intensive care units--causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure.

  1996cited by this paper
• Does the type of volume therapy influence endothelial-related coagulation in the critically ill?

  1995cited by this paper
• Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors.

  1994cited by this paper
• Intravenous immunoglobulin-induced osmotic nephrosis.

  1994cited by this paper
• Guidelines for the Use of Innovative Therapies in Sepsis

  1993cited by this paper
• Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation.

  1993cited by this paper
• Proximal renal tubular vacuolization induced by iodinated contrast media, or so-called "osmotic nephrosis".

  1993cited by this paper
• A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study.

  1993cited by this paper
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

  1992cited by this paper
• [Hydroxyethyl starch-induced transient renal failure in preexisting glomerular damage].

  1991cited by this paper
• Acute renal failure in the medical intensive care unit: predisposing, complicating factors and outcome.

  1991cited by this paper
• Acquired renal insufficiency in critically ill patients.

  1988cited by this paper
• Elevated urinary specific gravity in acute oliguric renal failure due to hetastarch administration.

  1988cited by this paper
• Elevated urinary specific gravity in acute oliguric renal failure due to hetastarch administration.

  1988cited by this paper
• Acute renal failure associated with elevated plasma oncotic pressure.

  1987cited by this paper
• Acute renal failure in an intensive care unit: incidence, prediction and outcome

  1983cited by this paper
• Effects of Dextran 40 on Urine Flow and Composition during Renal Hypoperfusion in Dogs with Osmotic Nephrosis

  1970cited by this paper
• Tubular alterations produced by osmotic diuresis with mannitol.

  1965cited by this paper

• Intraoperative Colloid Use on Post-operative Renal Function

  2024cites this paper
• Association Does Not Mean Causation, When Observational Data Were Misinterpreted as Causal: The Observational Interpretation Fallacy.

  2024cites this paper
• pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy.

  2021cites this paper
• The effect of HES130/0.4 sodium chloride solution on kidney function following early fluid resuscitation in shock patients

  2021cites this paper
• The effect of tetrastarch solution for capillary leak syndrome following allogeneic hematopoietic stem cell transplantation: A report of 2 cases

  2021cites this paper
• Preparation and characterization of 2-hydroxyethyl starch microparticles for co-delivery of multiple bioactive agents

  2021cites this paper
• Comparative effects of human albumin versus modern hydroxyethyl starch in living-donor renal transplant

  2019cites this paper
• Fluid therapy and outcome: a prospective observational study in 65 German intensive care units between 2010 and 2011

  2018cites this paper
• Hematologic Challenges in the Critically Ill

  2018cites this paper
• Is Brain-Dead Donor Fluid Therapy With Colloids Associated With Better Kidney Grafts?

  2018cites this paper
• Sepsis in adults

  2018cites this paper
• Perioperative fluid therapy: defining a clinical algorithm between insufficient and excessive.

  2016cites this paper
• Use of hydroxyethyl starch in leukocytapheresis procedures does not increase renal toxicity

  2016cites this paper
• Hydroxyethyl starch - friend or foe?

  2016cites this paper
• Renal protection in cardiovascular surgery

  2016cites this paper
• Impact of 6% Starch 130/0.4 and 4% Gelatin Infusion on Kidney Function in Living-Donor Liver Transplantation.

  2015cites this paper
• Postoperative fluid management.

  2015cites this paper
• Controversies in the use of hydroxyethyl starch solutions in small animal emergency and critical care.

  2015cites this paper
• The crystalloid-colloid debate: Consequences of resuscitation fluid selection in veterinary critical care.

  2015cites this paper
• Hydroxyethyl starch and granulocyte transfusions: considerations of utility and toxicity profile for patients and donors

  2015cites this paper
• Crystalloids and colloids in critical patient resuscitation

  2015cites this paper
• Crystalloids and colloids in critical patient resuscitation.

  2015cites this paper
• Postoperative renal replacement therapy after hydroxyethyl starch infusion: a meta-analysis of randomised trials

  2014cites this paper
• Molecular Size and Origin Do Not Influence the Harmful Side Effects of Hydroxyethyl Starch on Human Proximal Tubule Cells (HK-2) In Vitro

  2014cites this paper
• Perioperative Gabe von balancierter kristalloider versus balancierter kolloidaler Lösung innerhalb eines zielorientierten Hämodynamikprotokolls bei Patientinnen mit primärem Ovarialkarzinom

  2014cites this paper
• What's new in volume therapy in the intensive care unit?

  2014cites this paper
• Hydroxyethyl starches in the perioperative period. A review on the efficacy and safety of starch solutions.

  2014cites this paper
• Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.

  2013cites this paper
• Fluid therapy in critical illness: a special focus on indication, the use of hydroxyethyl starch and its different raw materials.

  2013cites this paper
• CSN Commentary Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury

  2013cites this paper
• The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch.

  2013cites this paper
• Fluid prescribing on a tertiary centre general surgical ward. Are we adhering to the British consensus guidelines on intravenous fluid therapy for adult surgical patients (GIFTASUP)

  2013cites this paper
• Colloids in Sepsis: Evenly Distributed Molecules Surrounded by Uneven Questions

  2013cites this paper
• OPINION Fluid management in thoracic surgery

  2013cites this paper
• World incidence of AKI: a meta-analysis.

  2013cites this paper
• Hydroxyethyl starch for fluid resuscitation in critically ill patients

  2013cites this paper
• Acute kidney injury by hydroxyethyl starch : Can the risks be mitigated ?

  2013influential citation
• Fluid management in thoracic surgery

  2013cites this paper
• Fluid management and use of diuretics in acute kidney injury.

  2013cites this paper
• Bioresponsive HES-PEI conjugates for controlled shielding and deshielding of pDNA polyplexes

  2013cites this paper
• Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients

  2012cites this paper
• Controlled shielding and deshielding of gene delivery polyplexes using hydroxyethyl starch (HES) and alpha-amylase.

  2012cites this paper
• Cardiovascular Management of Septic Shock in 2012

  2012cites this paper
• Section 3: Prevention and Treatment of AKI

  2012cites this paper
• Possible interventional therapies in severe sepsis or septic shock.

  2012cites this paper
• Impairment of renal function using hyperoncotic colloids in a two hit model of shock: a prospective randomized study

  2012cites this paper
• Fluid management in thoracic surgery.

  2012cites this paper
• Fluid management and risk factors for renal dysfunction in patients with severe sepsis and/or septic shock

  2012influential citation
• Optimizing fluid management in critically ill patients

  2012cites this paper
• Effet de l'Hydroxyéthylamidon 6% 130/0,4 sur la fonction rénale après chirurgie cardiaque

  2012cites this paper
• Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.

  2012cites this paper
• Are renal adverse effects of hydroxyethyl starches merely a consequence of their incorrect use?

  2011cites this paper
• Intravascular volume therapy with colloids in cardiac surgery.

  2011cites this paper
• Flüssigkeits- und Volumentherapie in der Intensivmedizin

  2011cites this paper
• The efficacy and safety of colloid resuscitation in the critically ill.

  2011cites this paper
• A Systematic Review of Third-Generation Hydroxyethyl Starch (HES 130/0.4) in Resuscitation: Safety Not Adequately Addressed

  2011cites this paper
• Association of 6% hetastarch resuscitation with adverse outcomes in critically ill trauma patients.

  2011cites this paper
• Update on the Comparative Safety of Colloids: A Systematic Review of Clinical Studies

  2011cites this paper
• Perioperative fluid and volume management: physiological basis, tools and strategies

  2011cites this paper
• The Efficacy and Safety of Colloid Resuscitation in the Critically Ill

  2011cites this paper
• Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective).

  2011cites this paper
• Standard perioperative management in gastrointestinal surgery

  2011cites this paper
• Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma).

  2011cites this paper
• Type of fluid in severe sepsis and septic shock.

  2011cites this paper
• Short-term effects of hydroxyethylstarch resuscitation on systemic and regional hemodynamics and metabolism in a brain-dead canine model.

  2011cites this paper
• Use of synthetic colloids in sepsis: a critical review on efficacy, safety and patient benefits.

  2011cites this paper
• [Volume replacement in intensive care medicine].

  2011cites this paper
• Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: A prospective sequential comparison*

  2011cites this paper
• Colloid solutions: a clinical update

  2010cites this paper
• Prevention of acute kidney injury and protection of renal function in the intensive care unit

  2010cites this paper
• Acute kidney injury in the intensive care unit: An update and primer for the intensivist

  2010cites this paper
• Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury

  2010cites this paper
• Taking the septic patient to the operating room.

  2010cites this paper
• What is stopping us from early mobility in the intensive care unit?

  2010cites this paper
• That Allogeneic Transfusion Is

  2010cites this paper
• Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4

  2010cites this paper
• Hydroxyethyl starches: Plus ça change, plus c'est la même chose.

  2010cites this paper
• International Albumin Use: 1995 to 2006

  2010cites this paper
• PERBEDAAN PENGARUH PEMBERIAN INFUS HES DENGAN BERAT MOLEKUL 40 KILODALTON DAN 200 KILODALTON TERHADAP JUMLAH PRODUKSI URIN

  2010cites this paper
• Hydroxyéthylamidons : la tolérance en pathologie humaine

  2010cites this paper
• Comment on Reference to Maximum Dose for Starch

  2010cites this paper
• Phase II trial on the use of Dextran 70 or starch for supportive therapy in Kenyan children with severe malaria*

  2010cites this paper
• To dose or not to dose: that is the (starch) question ...

  2010cites this paper
• Hydroxyethylstarch supplementation in burn resuscitation--a prospective randomised controlled trial.

  2010cites this paper
• Why do intensivists still use hydroxyethyl starch?

  2010cites this paper
• The impact of crystalloid and colloid infusion on the kidney in rodent sepsis

  2010influential citation
• The renal effect of replacement fluids in controlled severe hemorrhagic shock: an experimental study.

  2009cites this paper
• Pro/con debate: Should synthetic colloids be used in patients with septic shock?

  2009cites this paper
• The Safety of Modern Hydroxyethyl Starch in Living Donor Liver Transplantation: A Comparison with Human Albumin

  2009cites this paper
• PRO: hydroxyethylstarch can be safely used in the intensive care patient—the renal debate

  2009cites this paper
• CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients

  2009cites this paper
• Epoetin alfa in the critically ill: What dose? Which route?

  2009cites this paper
• Acute kidney injury by hydroxyethyl starch: Can the risks be mitigated?

  2009cites this paper
• Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials

  2009cites this paper
• Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion model

  2009cites this paper
• British consensus guidelines on intravenous fluid therapy for adult surgical patients (GIFTASUP) – Cassandra’s view

  2009cites this paper
• Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients

  2009cites this paper
• Are All Colloids Same? How to Select the Right Colloid?

  2009cites this paper
• Hydroxyethyl starch interferes with human blood ex vivo coagulation, platelet function and sedimentation.

  2009cites this paper
• Relevance of non-albumin colloids in intensive care medicine.

  2009cites this paper